
The approval expands options for protecting infants from respiratory syncytial virus, which remains a leading cause of pediatric hospitalization.
Aryanna LeBron is a 2025 PharmD candidate at the University of Connecticut School of Pharmacy, in Storrs, Connecticut.

The approval expands options for protecting infants from respiratory syncytial virus, which remains a leading cause of pediatric hospitalization.


Published: October 21st 2025 | Updated: